THOUSAND OAKS, Calif., Aug. 26, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced today that it has entered into an agreement with Celgene Corporation (NASDAQ: CELG) in connection with its previously announced merger with Bristol-Myers Squibb Company (NYSE: BMY) to acquire worldwide rights to Otezla® (apremilast), the only oral, non-bio

IRVINE, Calif., Aug. 26, 2019 /PRNewswire/ -- MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies under its MolDx program, has issued a draft local coverage determination (LCD) for the SelectMDx

SAN DIEGO, Aug. 26, 2019 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company") today announced the last patient has completed her last visit in AMPREVENCE, the Phase 2b clinical trial evaluating the Company's lead product candidate Amphora®, a Multipurpose Vaginal pH Regulator (MVP-R™), for the p

LAS VEGAS, Aug. 26, 2019 /PRNewswire/ -- As the CDC reports that 69 percent of reported West Nile virus cases have been diagnosed with the more severe neuroinvasive disease,  a scientific paper recently published in the peer-reviewed journal, Nature Communications, offers an explanation as to why some people infected with West Nile virus have no symptoms

FLOWER MOUND, Texas, Aug. 26, 2019 /PRNewswire/ -- CBDOilUsers.com, a leading CBD oil education website for consumers, has published its list of the best Labor Day CBD sales from top brands, available at

BALTIMORE and MEMPHIS, Tenn., Aug. 26, 2019 /PRNewswire/ --

DAVIS, Calif., Aug. 26, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of cr

DAVIS, Calif., Aug. 26, 2019 /PRNewswire/ -- 

LUND, Sweden, Aug. 26, 2019 /PRNewswire/ -- The Australian Federal Health Minister Greg Hunt announced on Sunday that Camurus' long-acting medication Buvidal® Weekly and Monthly (buprenorphine) solutions for injection will be listed on the PBS. From September, Buvidal® will be fully subsidised as a part of a $

SUZHOU, China, Aug. 25, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that the first patient in China has been dosed in the Phase I/II bridging study of avapritinib, which was discovered by CStone's partner Blueprint Medicines. This stand-alone registrational bridging study in